167 related articles for article (PubMed ID: 33389881)
21. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y
Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177
[TBL] [Abstract][Full Text] [Related]
22. LncRNA DANCR upregulation induced by TUFT1 promotes malignant progression in triple negative breast cancer via miR-874-3p-SOX2 axis.
Wu G; Zhou H; Li D; Zhi Y; Liu Y; Li J; Wang F
Exp Cell Res; 2020 Nov; 396(2):112331. PubMed ID: 33058834
[TBL] [Abstract][Full Text] [Related]
23. Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer.
Mitobe Y; Ikeda K; Sato W; Kodama Y; Naito M; Gotoh N; Miyata K; Kataoka K; Sasaki H; Horie-Inoue K; Inoue S
Cancer Sci; 2020 Jul; 111(7):2440-2450. PubMed ID: 32437068
[TBL] [Abstract][Full Text] [Related]
24. LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer.
Lv M; Xu P; Wu Y; Huang L; Li W; Lv S; Wu X; Zeng X; Shen R; Jia X; Yin Y; Gu Y; Yuan H; Xie H; Fu Z
Oncotarget; 2016 Mar; 7(11):13047-59. PubMed ID: 26910840
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNAs in triple-negative breast cancer: A new frontier in the regulation of tumorigenesis.
Thakur KK; Kumar A; Banik K; Verma E; Khatoon E; Harsha C; Sethi G; Gupta SC; Kunnumakkara AB
J Cell Physiol; 2021 Dec; 236(12):7938-7965. PubMed ID: 34105151
[TBL] [Abstract][Full Text] [Related]
26. The role of FOXC1/FOXCUT/DANCR axis in triple negative breast cancer: a bioinformatics and experimental approach.
Kamaliyan Z; Mirfakhraie R; Azizi-Tabesh G; Darbeheshti F; Omranipour R; Ahmadinejad N; Zokaei E; Yassaee VR
Mol Biol Rep; 2022 Apr; 49(4):2821-2829. PubMed ID: 35066769
[TBL] [Abstract][Full Text] [Related]
27. A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.
Wang PS; Chou CH; Lin CH; Yao YC; Cheng HC; Li HY; Chuang YC; Yang CN; Ger LP; Chen YC; Lin FC; Shen TL; Hsiao M; Lu PJ
Oncogene; 2018 Aug; 37(34):4662-4678. PubMed ID: 29755127
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis.
Gao S; Zhao ZY; Wu R; Zhang Y; Zhang ZY
Onco Targets Ther; 2018; 11():4877-4891. PubMed ID: 30147339
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis.
Gao G; Wang Z; Qu X; Zhang Z
BMC Cancer; 2020 Mar; 20(1):179. PubMed ID: 32131780
[TBL] [Abstract][Full Text] [Related]
30. Advances in Pathophysiology of Triple-Negative Breast Cancer: The Potential of lncRNAs for Clinical Diagnosis, Treatment, and Prognostic Monitoring.
Zhou Y; Yue Y; Fan S; Jia Q; Ding X
Mol Biotechnol; 2021 Dec; 63(12):1093-1102. PubMed ID: 34245439
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.
Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C
J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262
[TBL] [Abstract][Full Text] [Related]
32. LncRNA GATA3-AS1 facilitates tumour progression and immune escape in triple-negative breast cancer through destabilization of GATA3 but stabilization of PD-L1.
Zhang M; Wang N; Song P; Fu Y; Ren Y; Li Z; Wang J
Cell Prolif; 2020 Sep; 53(9):e12855. PubMed ID: 32687248
[TBL] [Abstract][Full Text] [Related]
33. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling.
Zheng S; Li M; Miao K; Xu H
J Cell Biochem; 2020 Mar; 121(3):2225-2235. PubMed ID: 31692053
[TBL] [Abstract][Full Text] [Related]
34. Long Non-Coding RNA Expression in Laser Micro-Dissected Luminal A and Triple Negative Breast Cancer Tissue Samples-A Pilot Study.
Marcu A; Nitusca D; Vaduva A; Baderca F; Cireap N; Coricovac D; Dehelean CA; Seclaman E; Ilina R; Marian C
Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33921283
[No Abstract] [Full Text] [Related]
35. Revealing the Potential Markers of N(4)-Acetylcytidine through acRIP-seq in Triple-Negative Breast Cancer.
Zhang X; Zeng J; Wang J; Yang Z; Gao S; Liu H; Li G; Zhang X; Gu Y; Pang D
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553667
[TBL] [Abstract][Full Text] [Related]
36. Co-expression networks revealed potential core lncRNAs in the triple-negative breast cancer.
Yang F; Liu YH; Dong SY; Yao ZH; Lv L; Ma RM; Dai XX; Wang J; Zhang XH; Wang OC
Gene; 2016 Oct; 591(2):471-7. PubMed ID: 27380926
[TBL] [Abstract][Full Text] [Related]
37. Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer.
Yang Q; Fu Y; Wang J; Yang H; Zhang X
J Zhejiang Univ Sci B; 2023 Dec; 24(12):1123-1140. PubMed ID: 38057269
[TBL] [Abstract][Full Text] [Related]
38. Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value.
Jiang YZ; Liu YR; Xu XE; Jin X; Hu X; Yu KD; Shao ZM
Cancer Res; 2016 Apr; 76(8):2105-14. PubMed ID: 26921339
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness.
Shin VY; Chen J; Cheuk IW; Siu MT; Ho CW; Wang X; Jin H; Kwong A
Cell Death Dis; 2019 Mar; 10(4):270. PubMed ID: 30894512
[TBL] [Abstract][Full Text] [Related]
40. Roles and expression profiles of long non-coding RNAs in triple-negative breast cancers.
Kong X; Liu W; Kong Y
J Cell Mol Med; 2018 Jan; 22(1):390-394. PubMed ID: 28941134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
